google_counter
Booking Health Blog / page 2

Medical Blog About Treatment Abroad

Welcome to our medical blog – it is dedicated to empowering patients with knowledge about global healthcare! We created this platform with the intention to bridge the gap between patients and the medical innovations available globally.

What's Inside: Discover new and rare methods in oncology, immunology, heart surgery, neurosurgery, and other medical fields! Our health travel insights show how medical journeys open new possibilities with advanced treatments unavailable locally, including specialized cancer care abroad.

Who Benefits: This resource is for patients and their families who seek new treatment methods and explore options at leading international hospitals. Those who want to make informed healthcare decisions beyond borders.

Why Read: Booking Health experts provide verified information through patient-friendly articles – they translate complex medical advances into accessible info. Stay current with the latest developments in global healthcare and discover how international medicine can transform treatment outcomes!

Browse our latest articles and take the first step toward better health outcomes!

Latest posts - page 2

placeholder Stem Cell Therapy in Germany

Germany is one of the most preferred destinations for stem cell therapy thanks to its strong scientific background, reliable healthcare system, and many clinics where this kind of therapy is carried out. Because of that, the country has become a place of choice for international patients looking for new medical solutions in regenerative medicine.


placeholder Immunotherapy treatment for liver cancer in Germany

Hepatocellular carcinoma (HCC) is the most widespread form of liver cancer, and it is believed to be one of the leading causes of cancer-related deaths on earth. The sixth most common malignancy and the third most common cause of death due to cancer in the world is liver cancer. The most common of these is hepatocellular carcinoma...


placeholder Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer diagnosis among men and remains one of the leading causes of cancer-related deaths worldwide. According to GLOBOCAN 2018, more than 1,276,000 new cases were reported globally, with a particularly high incidence in developed countries. The risk of developing prostate...


placeholder
Oncology
Ependymoma Treatment

Ependymomas (EPN) represent approximately 5% of all central nervous system cancers – rare enough that many oncologists encounter only a handful of cases throughout their careers. The rarity creates a challenge: this brain tumor treatment protocols lack the robust evidence base found in more common cancers. That is why expertise...


placeholder
Stage 4 cancer
Stage 4 Bladder Cancer: Comprehensive Guide and Treatment Options

Bladder cancer stage 4 is the most advanced form of the disease. It is characterized by the spread of cancer cells beyond the bladder (to distant lymph nodes, liver, lungs and even bones). According to statistics bladder cancer is among the most common malignancies worldwide with an estimated 573,000 new cases diagnosed annually and...


placeholder Stem cell treatment for Lyme Disease

Сaused by the bacterium Borrelia burgdorferi, Lyme disease is a tick-borne infection. It's on the rise worldwide – nearly 476,000 Americans are diagnosed each year, though officially reported cases number only around 30,000. Without antibiotic treatment, the infection progresses through three stages and can affect skin, joints...


placeholder
Oncology
Medulloblastoma Treatment Options for Adults

Medulloblastoma is most commonly associated with children but it can also occur in adults (although it is much rarer). Statistical data show, that adult medulloblastoma accounts for less than 1% of all primary brain tumors. Typically, it originates in the cerebellum ー this is the part of the brain responsible for balance, coordination and...


placeholder
Oncology
Pancreatic Cancer Treatment: Guideline for Treatment Options

Pancreatic cancer (PC) remains one of the most aggressive forms of gastrointestinal carcinomas. Just imagine that in 2022, approximately 467,000 deaths were attributed to this disease; that places PC among the top six causes of cancer-related mortality worldwide.The overall 5-year survival rate sits around 13%. That is a horrific statistic. For localized...